• TEVA

Earnings call: Teva Pharmaceuticals sees growth amid challenges in Q3 2024

• TEVA

Teva ADR earnings beat by $0.03, revenue topped estimates

Teva ADR reported better-than-expected Q3 EPS and revenue, with stock climbing 7.69% in three months. Financial health is rated as great performance.

• TEVA

Teva to pay $450 million to resolve US kickback, price-fixing cases

Teva Pharmaceutical agrees to pay $450 million to settle allegations of using charities to pay kickbacks related to Copaxone and price-fixing for generics.

• BEZQ
• TA35
• TEVA
• TSEM

Israel stocks lower at close of trade; TA 35 down 0.94%

Israeli stocks declined 0.94%, driven down by losses in Banking, Real Estate, and Oil & Gas; crude and gold prices rose amidst mixed currency values.